Skip to main content
48°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.65
+0.52 (+2.07%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets
September 25, 2024
From
Pfizer Inc.
Via
Business Wire
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
September 25, 2024
One of these is not like the other.
Via
The Motley Fool
Pfizer Unusual Options Activity
September 24, 2024
Via
Benzinga
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
September 24, 2024
These stocks are all trading at less than 12 times their estimated future earnings.
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Current Report: Pfizer (PFE)
September 19, 2024
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Over the past year, Pfizer's share price fell about 12.7% from $34.07 to $29.75 as of Wednesday’s...
Via
Talk Markets
Pfizer Unusual Options Activity
September 17, 2024
Via
Benzinga
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
September 16, 2024
Via
Benzinga
Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate
September 23, 2024
IDEAYA Biosciences released interim Phase 2 data that shows promising tumor shrinkage and eye preservation rates.
Via
Benzinga
2 Beaten-Down Stocks to Buy and Hold for a Decade
September 23, 2024
These innovative companies have the tools to rebound.
Via
The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
10 large-cap stocks worst performers in last week: SMMT -23.61%, KSPI -21.66%, BMRN -16.74%, RIVN -13.26%, FDX -11.08%, BNTX -9.01%, AJG -7.17%, CHWY -6.97%, NVO -6.93%, MUSA -6.90%
Via
Benzinga
3 Dirt Cheap Stocks to Buy Right Now
September 21, 2024
Bargain hunters should love these great stocks.
Via
The Motley Fool
Pfizer Advances On Its Cancer Journey
September 20, 2024
On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...
Via
Benzinga
Is Pfizer's 5.7% Dividend Yield Worth the Risk?
September 15, 2024
Pfizer's sky-high dividend yield is tempting, but is it sustainable?
Via
The Motley Fool
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 20, 2024
Via
Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
Pfizer Inc.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
September 18, 2024
Via
Benzinga
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
September 18, 2024
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and...
Via
Benzinga
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
September 18, 2024
After underperforming over the past few years, these stocks offer huge dividend yields that could keep rising throughout your retirement.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.
Via
The Motley Fool
Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call with Analysts
September 17, 2024
From
Pfizer Inc.
Via
Business Wire
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Telemedicine once seemed like it was going to revolutionize healthcare.
Via
The Motley Fool
Buy 3 High Dividend-Paying Stocks With Attractive Short-Term Returns
September 17, 2024
The September syndrome is already visible in U.S. stock markets. At this stage, investment in stocks with high dividend yield strong price appreciation potential in the short term should enhance...
Via
Talk Markets
Intel, Microsoft, Meta Platforms, Pfizer, Tesla: Why These 5 Stocks Are On Investors' Radars Today
September 16, 2024
On Monday, major U.S. indices showed mixed results. The Dow Jones Industrial Average closed 0.5% higher at 41,622.08
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
September 16, 2024
The company's best days as a top pandemic vaccine supplier might be over, but it still has enough potential to be compelling.
Via
The Motley Fool
Topics
Supply Chain
Exposures
Supply Chain
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and...
Via
Benzinga
Exposures
COVID-19
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
September 16, 2024
Huntsville, Alabama--(Newsfile Corp. - September 16, 2024) - Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr....
Via
Newsfile
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
September 14, 2024
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.